• Explore /
  • Poster
  • / Individual patients data analysis (IPD) of three randomized studies comparing erlotinib (E) with chemotherapy (CT) in patients with advanced wild-type epidermal growth factor receptor (wtEGFR) non-small cell lung cancer (NSCLC).

Individual patients data analysis (IPD) of three randomized studies comparing erlotinib (E) with chemotherapy (CT) in patients with advanced wild-type epidermal growth factor receptor (wtEGFR) non-small cell lung cancer (NSCLC).

Abstract Poster

Authors

null

Valter Torri

IRCCS-Mario Negri Institute, Milano, Italy

Valter Torri , Masahiko Ando , Eliana Rulli , Irene Claudia Floriani , Tomoya Kawaguchi , Shun-ichi Isa , Vanesa Gregorc , Silvia Novello , Sandro Barni , Michela Cinquini , Silvia Marsoni , Gabriella Farina , Marina Chiara Garassino

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 33, 2015 (suppl; abstr 8048)

DOI

10.1200/jco.2015.33.15_suppl.8048

Abstract #

8048

Poster Bd #

371

Abstract Disclosures

Similar Posters

First Author: Raymond U Osarogiagbon

First Author: Vivek Agarwala

First Author: Chee Lee

First Author: Julien Mazières